Combined treatment of urinary bladder cancer with the use of photodynamic therapy (PDT) and subsequent BCG-therapy: A pilot study

Photodiagnosis and Photodynamic Therapy

Volumn 1, Issue 3, 2004, Pages 241-246

  Szygula, Michal ^a   Pietrusa, Artur ^a,b   Adamek, Mariusz ^a   Wojciechowski, Boguslaw ^a,c   Kawczyk Krupka, Aleksandra ^a   Cebula, Wojciech ^a   Duda, Wieslaw ^b   Sieron, Aleksander ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Urology Ward   (Poland)

^c City Hospital No 1   (Poland)

Author keywords

Aminolevulinic acid; BCG; Immunotherapy; Photodynamic therapy (PDT); Transitional cell cancer (TCC)

Indexed keywords

AMINOLEVULINIC ACID; BCG VACCINE; BUFFER;

ADULT; AGED; ARGON LASER; ARTICLE; BCG VACCINATION; BLADDER CARCINOMA; BLADDER DYSFUNCTION; BLADDER IRRITATION; BLADDER SPASM; BODY TEMPERATURE; CANCER IMMUNIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DYE LASER; DYSPLASIA; ENERGY; FEMALE; HEMATURIA; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIGHT EXPOSURE; MALE; MICROSCOPY; MULTIMODALITY CANCER THERAPY; PAIN; PHOTODYNAMIC THERAPY; PILOT STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SIDE EFFECT; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

MYCOBACTERIUM BOVIS BCG;

EID: 18144369250     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1572-1000(04)00067-5     Document Type: Article

References (17)

1. M.S. Soloway Bladder tumor markers, intravesical therapy and systemic chemotherapy J Urol 166 2001 488 489
2. A. Lopez-Beltran Bladder treatment. Immunotherapy and chemotherapy Urol Clin North Am 26 1999 535 554
3. J.C. Kim, and G.D. Steinberg Medical management of patients with refractory carcinoma in situ of the bladder Drugs Aging 18 2001 335 344
4. S.B. Malkowicz Intravesical therapy for superficial bladder cancer Semin Urol Oncol 18 2000 280 288
5. R. Waidelich, H. Stepp, R. Baumgartner, E. Weninger, A. Hofstetter, and M. Kriegmair Clinical experience with 5-amonilevulinic acid and photodynamic therapy for refractory superficial bladder cancer J Urol 165 1904-1907
6. A. Bohle, and C. Durek Recent perspectives in topical therapy in superficial bladder cancer Curr Opin Urol 9 1999 407 411
7. M.D. Shelley, H. Kyanaston, and T.J. Court A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs. transurethral resection alone in Ta and T1 bladder cancer BJU Int 88 2001 209 216
8. J.A. Smith Jr., R.F. Labasky, A.T.K. Cockett, J.A. Francchia, J.E. Montie, and R.G. Rowland Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1, and TIS) J Urol 162 1999 1697 1702
9. A.M. Kamat, and D.L. Lamm Intravessical therapy for bladder cancer Urology 55 2000 161 168
10. E.C. Baseli, and R.E. Greenberg Intravesical therapy for superficial bladder cancer Oncology (Huntingt) 14 2000 719 729
11. D.C. Shackley, C. Whitehurst, J.V. Moore, N.J. George, C.D. Betts, and N.W. Clarke Light penetration in bladder tissue: implicatioms for the intravesical photodynamic therapy of bladder tumours BJU Int 86 2000 638 643
12. B. Wojciechowski, M. Szygula, and A. Sieron Efficiency of autofluorescence diagnosis and photodynamic therapy (PDT) of bladder tumours: our own experience Proc SPIE 4156 2001 201 207
13. S. Iinuma, K.T. Schomacker, and G. Wagnieres In vivo fluence rate of fractionation effects on tumour response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumour model Cancer Res 59 1999 6164 6170
14. U.O. Nseyo Sequential whole bladder photodynamic therapy (WBPT) in management of recurrent superficial bladder cancer Proc SPIE 4156 2001 212 217
15. U.O. Nseyo, J. DeHaven, and T.J. Dougherty Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a ling-term experience J Clin Laser Med Surg 16 1998 61 68
16. J. Seidl, J. Rauch, R.C. Krieg, S. Appel, R. Baumgartner, and R. Knuechel Optimization of differential photodymanic effectiveness between normal and tumour urothelial cells using 5-aminolevulinic acid-induced protopophirin IX as photosensitizer Int J Cancer 92 2001 671 677
17. M.M. Walther The role of photodynamic therapy in the treatment of recurrent superficial bladder cancer Urol Clin North Am 27 2000 163 170